Convertible Note Purchase AgreementConvertible Note Purchase Agreement • July 3rd, 2014 • Raptor Pharmaceutical Corp • Pharmaceutical preparations • New York
CONVERTIBLE NOTE PURCHASE AGREEMENT (this "Agreement"), dated as of July 1, 2014 between Raptor Pharmaceutical Corp., a company duly incorporated and existing under the laws of Delaware, United States of America, and having its principal office at 5 Hamilton Landing, Suite 160, Novato, CA 94949 as Issuer (the "Company"), HealthCare Royalty Partners II, L.P., as Holder, HCRP Overflow Fund, L.P., as Holder, MOLAG Healthcare Royalty, LLC, as Holder (each, a "Holder" and collectively, the "Holders"), and the Guarantors (as defined below) from time to time party hereto.
